Kikkoman Biochemifa Company (KBC) has announced the appointment of Yoshiaki Asami as its new President, effective 1 April 2025. Asami steps into the role following the retirement of Dr. Kajiyama, whose tenure marked a significant period of innovation and international growth for the company.
Currently serving as an executive corporate officer at Kikkoman Corporation and a senior executive corporate officer at Kikkoman Food Products Company, Asami brings over four decades of experience in sales and marketing. His leadership has been defined by a commitment to customer value and close collaboration, which are qualities that KBC hopes will galvanise into action its next phase of development in the global hygiene and biochemical testing markets.
Asami expresses gratitude for the foundation laid by his predecessor.
“Dr. Kajiyama’s vision has propelled KBC to new heights. I’m honoured to build upon that legacy and lead our talented team into the future,” he says in a statement.
Reflecting on his career, Asami emphasised the importance of adaptability, trust, and integrity. “Our mission is to contribute to healthier and safer lives by making the invisible power of microorganisms visible and useful. That means being a solution-driven company that stays close to our customers’ challenges,” he says.
KBC, a subsidiary of the Kikkoman Group, plays a crucial role in global health and safety through the production of pharmaceutical ingredients, diagnostic enzymes, and food sanitation tools. Asami noted the company’s potential to deepen its impact by combining science and technology with strong global partnerships.
Looking ahead, Asami outlined a strategy focused on customer-centric innovation and “professional all-in teamwork.” He also vows to enhance internal collaboration and review work styles in ultimately improving agility and responsiveness.
“With the world changing rapidly, KBC must continue to evolve,” Asami said. “We aim to deliver quality products and be a source of insight, support, and genuine partnership.”
Asami’s leadership marks a new chapter for KBC as it positions itself for continued global relevance and scientific advancement in a fast-shifting landscape.
